| Previous Close | 77.38 |
| Open | 77.53 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 77.53 - 78.65 |
| 52 Week Range | 64.18 - 86.72 |
| Volume | 2,131,886 |
| Avg. Volume | 3,551,871 |
| Market Cap | 81.95B |
| Beta | 0.15 |
| PE Ratio (TTM) | 37.84 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Dividend & Yield | 2.08 (2.69%) |
| Ex-Dividend Date | 2017-08-11 |
| 1y Target Est | N/A |
- The Wall Street Journal•6 hours ago
[$$] Eli Lilly, Topas Therapeutics Join Together in Autoimmune Disease Alliance
Topas Therapeutics GmbH, which last year sold venture firms on its technology for developing autoimmune-disease treatments, has now won over a large pharmaceutical company.
- Market Realist•11 hours ago
Understanding Incyte’s 2Q17 Revenue Stream
Incyte's 2Q17 revenue growth was driven by the increased demand for Jakafi.
Markit•17 hours agoSee what the IHS Markit Score report has to say about Eli Lilly And Co.
Eli Lilly And Co NYSE:LLY
